JITC

Outcomes of vedolizumab therapy in patients with immune checkpoint inhibitor–induced colitis: a multi-center study
Hamzah Abu-Sbeih, Faisal S. Ali, Dana Alsaadi, Joseph Jennings, Wenyi Luo, Zimu Gong, David M. Richards, Aline Charabaty, Yinghong Wang

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 142; DOI: 10.1186/s40425-018-0461-4
High and low mutational burden tumors versus immunologically hot and cold tumors and response to immune checkpoint inhibitors
Saman Maleki Vareki

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 157; DOI: 10.1186/s40425-018-0479-7
Acquired resistance to immunotherapy in MMR-D pancreatic cancer
Zishuo Ian Hu, Matthew D. Hellmann, Jedd D. Wolchok, Monika Vyas, Jinru Shia, Zsofia K. Stadler, Luis A. Diaz, Eileen M. O’Reilly

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 127; DOI: 10.1186/s40425-018-0448-1
Adjuvant NY-ESO-1 vaccine immunotherapy in high-risk resected melanoma: a retrospective cohort analysis
Michael Lattanzi, Joseph Han, Una Moran, Kierstin Utter, Jeremy Tchack, Rachel Lubong Sabado, Russell Berman, Richard Shapiro, Hsin-Hui Huang, Iman Osman, Nina Bhardwaj, Anna C. Pavlick

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 38; DOI: 10.1186/s40425-018-0345-7
Efficacy of PD-1 & PD-L1 inhibitors in older adults: a meta-analysis
Rawad Elias, Anita Giobbie-Hurder, Nadine Jackson McCleary, Patrick Ott, F. Stephen Hodi, Osama Rahma

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 26; DOI: 10.1186/s40425-018-0336-8
Cost-effectiveness of nivolumab plus ipilimumab as first-line therapy in advanced renal-cell carcinoma
Bin Wu, Qiang Zhang, Jie Sun

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 124; DOI: 10.1186/s40425-018-0440-9
Incorporating Radiation Oncology into Immunotherapy: proceedings from the ASTRO-SITC-NCI immunotherapy workshop
Ariel E. Marciscano, Joshua M. Walker, Heather M. McGee, Michelle M. Kim, Charles A. Kunos, Arta M. Monjazeb, Stephen L. Shiao, Phuoc T. Tran, Mansoor M. Ahmed

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 6; DOI: 10.1186/s40425-018-0317-y
Tumor-derived exosomal HMGB1 fosters hepatocellular carcinoma immune evasion by promoting TIM-1⁺ regulatory B cell expansion
Linsen Ye, Qi Zhang, Yusheng Cheng, Xiaolong Chen, Guoying Wang, Mengchen Shi, Tong Zhang, Yingjiao Cao, Hang Pan, Liting Zhang, Genshu Wang, Yinan Deng, Yang Yang, Guihua Chen

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 145; DOI: 10.1186/s40425-018-0451-6
Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination
Tyler W. Hulett, Shawn M. Jensen, Phillip A. Wilmarth, Ashok P. Reddy, Carmen Ballesteros-Merino, Michael E. Afentoulis, Christopher Dubay, Larry L. David, Bernard A. Fox

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 27; DOI: 10.1186/s40425-018-0331-0
A severe case of neuro-Sjögren’s syndrome induced by pembrolizumab
Jaqueline Ghosn, Alex Vicino, Olivier Michielin, George Coukos, Thierry Kuntzer, Michel Obeid

Journal for ImmunoTherapy of Cancer Dec 2018, 6 (1) 110; DOI: 10.1186/s40425-018-0429-4

Main menu

JITC

Pages

Log in using your username and password

Main menu

Log in using your username and password

You are here

JITC

Pages